These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19584721)

  • 1. The physiological impact of the serum and glucocorticoid-inducible kinase SGK1.
    Lang F; Artunc F; Vallon V
    Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):439-48. PubMed ID: 19584721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the epithelial Na+ channel by the mTORC2/SGK1 pathway.
    Lang F; Pearce D
    Nephrol Dial Transplant; 2016 Feb; 31(2):200-5. PubMed ID: 26163195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth.
    Lang F; Stournaras C
    Hormones (Athens); 2013; 12(2):160-71. PubMed ID: 23933686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inducible kidney-specific Sgk1 knockout mice show a salt-losing phenotype.
    Faresse N; Lagnaz D; Debonneville A; Ismailji A; Maillard M; Fejes-Toth G; Náray-Fejes-Tóth A; Staub O
    Am J Physiol Renal Physiol; 2012 Apr; 302(8):F977-85. PubMed ID: 22301619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGK, renal function and hypertension.
    Lang F; Huang DY; Vallon V
    J Nephrol; 2010; 23 Suppl 16(0 16):S124-9. PubMed ID: 21170869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure.
    Vallon V; Lang F
    Curr Opin Nephrol Hypertens; 2005 Jan; 14(1):59-66. PubMed ID: 15586017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of serum and glucocorticoid inducible kinase inhibition.
    Lang F; Voelkl J
    Expert Opin Investig Drugs; 2013 Jun; 22(6):701-14. PubMed ID: 23506284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blunted hypertensive effect of combined fructose and high-salt diet in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase SGK1.
    Huang DY; Boini KM; Friedrich B; Metzger M; Just L; Osswald H; Wulff P; Kuhl D; Vallon V; Lang F
    Am J Physiol Regul Integr Comp Physiol; 2006 Apr; 290(4):R935-44. PubMed ID: 16284089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal tubular SGK1 deficiency causes impaired K+ excretion via loss of regulation of NEDD4-2/WNK1 and ENaC.
    Al-Qusairi L; Basquin D; Roy A; Stifanelli M; Rajaram RD; Debonneville A; Nita I; Maillard M; Loffing J; Subramanya AR; Staub O
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F330-42. PubMed ID: 27009335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses to diuretic treatment in gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1.
    Artunc F; Ebrahim A; Siraskar B; Nasir O; Rexhepaj R; Amann K; Friedrich B; Risler T; Lang F
    Kidney Blood Press Res; 2009; 32(2):119-27. PubMed ID: 19401625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).
    García-Martínez JM; Alessi DR
    Biochem J; 2008 Dec; 416(3):375-85. PubMed ID: 18925875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and phosphorylation of the Na+-Cl- cotransporter NCC in vivo is regulated by dietary salt, potassium, and SGK1.
    Vallon V; Schroth J; Lang F; Kuhl D; Uchida S
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F704-12. PubMed ID: 19570885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and Glucocorticoid Regulated Kinase 1 in Sodium Homeostasis.
    Lou Y; Zhang F; Luo Y; Wang L; Huang S; Jin F
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27517916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulated NH2-terminal Sgk1 variant with enhanced function is expressed in the collecting duct.
    Raikwar NS; Liu KZ; Thomas CP
    Am J Physiol Renal Physiol; 2012 Dec; 303(11):F1527-33. PubMed ID: 23034940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of a third conserved phosphorylation site in SGK1.
    Chen W; Chen Y; Xu BE; Juang YC; Stippec S; Zhao Y; Cobb MH
    J Biol Chem; 2009 Feb; 284(6):3453-60. PubMed ID: 19068477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone-induced Sgk1 relieves Dot1a-Af9-mediated transcriptional repression of epithelial Na+ channel alpha.
    Zhang W; Xia X; Reisenauer MR; Rieg T; Lang F; Kuhl D; Vallon V; Kone BC
    J Clin Invest; 2007 Mar; 117(3):773-83. PubMed ID: 17332896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of serum- and glucocorticoid-inducible kinase SGK1 in glucocorticoid regulation of renal electrolyte excretion and blood pressure.
    Boini KM; Nammi S; Grahammer F; Osswald H; Kuhl D; Lang F
    Kidney Blood Press Res; 2008; 31(4):280-9. PubMed ID: 18753797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sgk kinases and their role in epithelial transport.
    Loffing J; Flores SY; Staub O
    Annu Rev Physiol; 2006; 68():461-90. PubMed ID: 16460280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evolutionarily conserved N-terminal Sgk1 variant with enhanced stability and improved function.
    Raikwar NS; Snyder PM; Thomas CP
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1440-8. PubMed ID: 18753299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGK1 activation exacerbates diet-induced obesity, metabolic syndrome and hypertension.
    Sierra-Ramos C; Velazquez-Garcia S; Vastola-Mascolo A; Hernández G; Faresse N; Alvarez de la Rosa D
    J Endocrinol; 2020 Jan; 244(1):149-162. PubMed ID: 31600722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.